Bio-Techne Corporation
TECH
$55.89
-$1.96-3.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.64% | 3.85% | 5.23% | 4.72% | 4.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.64% | 3.85% | 5.23% | 4.72% | 4.46% |
| Cost of Revenue | 1.32% | 2.15% | 6.04% | 6.02% | 6.89% |
| Gross Profit | 1.80% | 4.72% | 4.82% | 4.08% | 3.27% |
| SG&A Expenses | -1.37% | 4.21% | 4.88% | 17.80% | 9.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.45% | 3.90% | 5.84% | 10.00% | 7.45% |
| Operating Income | 6.10% | 3.67% | 3.04% | -13.57% | -5.46% |
| Income Before Tax | -38.54% | -39.72% | -46.98% | -29.85% | -26.11% |
| Income Tax Expenses | 19.64% | 10.57% | 42.52% | 6.72% | 1.31% |
| Earnings from Continuing Operations | -48.71% | -48.26% | -56.34% | -35.14% | -29.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.71% | -48.26% | -56.34% | -35.14% | -29.45% |
| EBIT | 6.10% | 3.67% | 3.04% | -13.57% | -5.46% |
| EBITDA | 2.34% | 1.10% | 1.61% | -9.43% | -3.77% |
| EPS Basic | -48.18% | -48.17% | -56.71% | -35.34% | -29.62% |
| Normalized Basic EPS | 13.28% | 9.93% | 11.81% | -9.57% | -5.21% |
| EPS Diluted | -49.48% | -48.92% | -56.67% | -33.87% | -27.25% |
| Normalized Diluted EPS | 14.47% | 11.01% | 12.86% | -8.88% | -4.51% |
| Average Basic Shares Outstanding | -1.35% | -0.80% | -0.25% | 0.27% | 0.26% |
| Average Diluted Shares Outstanding | -2.31% | -1.66% | -1.04% | -0.48% | -0.41% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.92% | 0.92% | 1.29% | 0.55% | 0.42% |